The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cohort 1 results of a phase I study of autolytic immunotherapy of metastatic neuroendocrine neoplasms using intralesional rose bengal disodium.
 
Mark McGregor
Research Funding - Provectus (Inst)
Travel, Accommodations, Expenses - MSD
 
Timothy Jay Price
Consulting or Advisory Role - Amgen; Merck Serono (Inst); Roche (Inst)
Research Funding - AMGEN (Inst)
Travel, Accommodations, Expenses - Amgen
 
Gabby Cehic
Research Funding - Provectus (Inst)
 
Ian D. Kirkwood
Stock and Other Ownership Interests - Alcidion; CSL Limited; ResMed; Sonic Healthcare
Research Funding - Provectus (Inst)
 
Ruben Sebben
Research Funding - Provectus (Inst)
Travel, Accommodations, Expenses - GE Medical Systems
 
Jessica J. Reid
Research Funding - Provectus (Inst)
 
Susan Neuhaus
Research Funding - Provectus (Inst)
 
Eric Andrew Wachter
Employment - Provectus Biopharmaceuticals
Leadership - Provectus Biopharmaceuticals
Stock and Other Ownership Interests - Provectus Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - Named inventor on one or more US or international patents assigned to Provectus Biopharmaceuticals
 
Guy Maddern
Research Funding - Provectus (Inst)